Drugs / VEGF Plasmid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07443826 | Jun 2026 → Sep 2027 expected | muscular atrophy | Unlimited Biotechnology LLC | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VEGF Plasmid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07443826 ↗ |